Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Post by snrkidon Jun 04, 2008 10:58am
505 Views
Post# 15143547

Clear advantage over competition

Clear advantage over competitionThis trial was designed according to FDA dictated parameters which did not allow any comparison beyond "non-inferiority".  Yet the advantage becomes clear on all side-effects.  Advantage becomes clear also on "wide therapeutic window"  to allow wide adjustment without causing harm and yet retaining side effect profile benefits.  -Also-  it was mentioned that by co-incidence Tac arm patients had much better quality kidneys than any other arms.

happy trading....
snrkid.
Bullboard Posts